Key Insights
The global mastitis market, valued at $1.3 billion in 2025, is projected to expand at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2033. This growth is driven by the increasing demand for effective mastitis management solutions in response to rising global dairy production and associated economic losses from reduced milk yield, animal culling, and veterinary expenses. The heightened prevalence of mastitis and farmer awareness regarding disease prevention and treatment are significant market drivers. Advancements in diagnostic tools and therapies, including novel antibiotics, vaccines, and surgical techniques, further propel market expansion. The market is segmented by route of administration (intra-mammary, systemic), therapy (lactating, dry period), end-user (veterinary clinics, hospitals), mastitis type (clinical, sub-clinical), and product type (antibiotics, vaccines, surgical interventions, pain management, and others). The adoption of preventive strategies, such as enhanced hygiene and vaccination programs, also contributes to market growth.
Mastitis Market Market Size (In Billion)
Geographically, North America and Europe lead the market due to robust veterinary infrastructure and high dairy output. The Asia-Pacific region is expected to experience substantial growth, fueled by expanding dairy operations and increasing animal healthcare spending. Emerging markets in the Middle East, Africa, and South America offer evolving opportunities. Key industry players include Zoetis, Elanco, and Boehringer Ingelheim, alongside specialized firms. Continuous research and development efforts are focused on product innovation and market positioning. Future market dynamics will be influenced by technological advancements in mastitis prevention and treatment, regulatory policies on antibiotic use, and the overall health of global dairy cattle populations.
Mastitis Market Company Market Share
Mastitis Market: A Comprehensive Report (2019-2033)
This comprehensive report provides a detailed analysis of the global Mastitis Market, offering invaluable insights for stakeholders across the veterinary pharmaceutical and animal health sectors. With a study period spanning 2019-2033, a base year of 2025, and a forecast period of 2025-2033, this report meticulously examines market dynamics, competitive landscapes, and future growth trajectories. The report leverages extensive data analysis and industry expertise to deliver actionable strategies and informed decision-making. The total market size in 2025 is estimated at USD xx Million, showcasing significant growth opportunities.
Mastitis Market Structure & Competitive Dynamics
The Mastitis Market exhibits a moderately consolidated structure, with key players such as Elanco (Bayer AG), Boehringer Ingelheim International GmbH, and Zoetis Inc. holding significant market share. The market's competitive landscape is characterized by intense innovation, particularly in the development of novel therapies and diagnostic tools to address antibiotic resistance. Regulatory frameworks, varying across different geographies, significantly influence market access and product approvals. The market also witnesses considerable M&A activity, driven by the desire to expand product portfolios and geographical reach. For instance, the USD 20 Million investment in Mileutis Ltd. highlights the growing interest in alternative mastitis treatments.
- Market Concentration: Moderately Consolidated
- Innovation Ecosystem: High, with focus on antibiotic alternatives and diagnostic technologies.
- Regulatory Frameworks: Varying across regions, impacting market access.
- Product Substitutes: Limited, with focus primarily on different drug classes and treatment approaches.
- End-User Trends: Increasing demand for rapid diagnostics and effective, antibiotic-reducing treatments.
- M&A Activities: Frequent, driven by portfolio expansion and market share consolidation. Deal values vary widely, but significant investments demonstrate a commitment to growth in this sector.
Mastitis Market Industry Trends & Insights
The Mastitis Market is experiencing robust growth, driven by several key factors. The rising global dairy production necessitates effective mastitis management strategies to minimize economic losses. Technological advancements in diagnostics, particularly rapid on-site testing like the PortaReader, are streamlining disease detection and treatment. Consumer preferences are shifting toward antibiotic-free products, creating a surge in demand for alternative therapies. The market's CAGR during the forecast period (2025-2033) is projected to be xx%, driven by increasing awareness of mastitis' economic impact and the introduction of innovative solutions. Market penetration of advanced diagnostic tools is expected to increase significantly. Competitive dynamics remain intense, with companies investing heavily in R&D to maintain a competitive edge.
Dominant Markets & Segments in Mastitis Market
The North American region currently holds a dominant position in the Mastitis Market due to its large dairy industry and established veterinary infrastructure. However, Asia-Pacific is expected to exhibit significant growth in the coming years.
- By Route of Administration: Intra-mammary administration dominates the market due to its targeted delivery and efficacy.
- By Therapy: Treatments during the lactating period constitute a larger segment due to higher prevalence of clinical mastitis cases during this phase.
- By End User: Hospitals and veterinary clinics represent the largest end-user segment due to their established infrastructure and expertise in mastitis management.
- By Type: Clinical mastitis currently holds a larger market share than subclinical mastitis, but the increasing adoption of diagnostic tools is likely to boost the subclinical mastitis segment's growth.
- By Product: Antibiotics remain the dominant product category, but the increasing focus on antibiotic resistance is driving the growth of alternative treatments, such as vaccines and other immunotherapies.
Key drivers for regional dominance include favorable economic policies, robust veterinary infrastructure, and high dairy production.
Mastitis Market Product Innovations
Recent product innovations emphasize the development of rapid, point-of-care diagnostic tools like PortaCheck's PortaReader, enabling timely intervention and improved herd management. The emergence of alternative therapies focusing on the prevention and treatment of mastitis without relying on antibiotics is a significant technological trend. These innovations are gaining market traction due to their improved efficiency and suitability for diverse farming contexts.
Report Segmentation & Scope
This report comprehensively segments the Mastitis Market based on Route of Administration (Intra-mammary, Systemic), Therapy (Lactating Period, Dry Period), End User (Hospitals and Clinics, Veterinary Centers, Other End Users), Type (Clinical Mastitis, Sub-clinical Mastitis), and Product (Antibiotics, Surgery, Vaccines, Pain Killers, Other Products). Each segment's growth projections, market size estimations, and competitive dynamics are detailed within the report. Market size for each segment is expected to grow at varying rates throughout the forecast period, influenced by factors such as technological advancements, regulatory changes, and market penetration strategies.
Key Drivers of Mastitis Market Growth
The Mastitis Market's growth is fueled by several factors: the rising global demand for dairy products, leading to increased dairy farming and consequently higher mastitis prevalence; technological advancements in diagnostics and treatment options, particularly non-antibiotic therapies; and growing government initiatives focused on animal welfare and antibiotic resistance reduction. These factors are creating opportunities for market expansion and innovation.
Challenges in the Mastitis Market Sector
The Mastitis Market faces challenges such as the rising concern over antibiotic resistance, leading to stringent regulatory measures and limitations on antibiotic use; the high cost of advanced diagnostic tools and novel therapies; and the variability in mastitis prevalence across different geographical regions, posing difficulties for standardized treatment protocols. These factors can influence market growth rates and investment strategies.
Leading Players in the Mastitis Market
- Elanco (Bayer AG)
- Boehringer Ingelheim International GmbH
- Advanced Animal Diagnostics
- Merck & Co Inc
- Ceva
- Nimrod Veterinary Products Ltd
- ImmuCell Corporation
- West Way Health
- Norbrook
- DeLaval
- Zoetis Inc
Key Developments in Mastitis Market Sector
- October 2022: NovaQuest Capital Management invested over USD 20 Million in Mileutis Ltd., boosting the development of antibiotic-alternative mastitis treatments.
- August 2022: PortaCheck launched the PortaReader, a handheld device for rapid on-site detection of subclinical mastitis.
Strategic Mastitis Market Outlook
The Mastitis Market presents significant growth potential due to the increasing focus on animal health and welfare, the ongoing development of innovative diagnostic tools and treatment options, and the growing demand for sustainable dairy farming practices. Strategic opportunities exist for companies focusing on developing antibiotic-free therapies and expanding their market presence in emerging economies. The market is expected to witness continued consolidation through M&A activities, further shaping the competitive landscape.
Mastitis Market Segmentation
-
1. Type
- 1.1. Clinical Mastitis
- 1.2. Sub-clinical Mastitis
-
2. Product
- 2.1. Antibiotics
- 2.2. Surgery
- 2.3. Vaccines
- 2.4. Pain Killers
- 2.5. Other Products
-
3. Route of Administration
- 3.1. Intra-mammary
- 3.2. Systemic
-
4. Therapy
- 4.1. Lactating Period
- 4.2. Dry Period
-
5. End User
- 5.1. Hospitals and Clinics
- 5.2. Veterinary Centers
- 5.3. Other End Users
Mastitis Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America
Mastitis Market Regional Market Share
Geographic Coverage of Mastitis Market
Mastitis Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 7.2% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Incidence of the Disease; Increasing Product Launches for Animal Healthcare; Technological Advancements in the Field of Drug Discovery and Development
- 3.3. Market Restrains
- 3.3.1. Rising Threat of Antibiotic Resistance; Lack of Awareness About the Disease
- 3.4. Market Trends
- 3.4.1. Clinical Mastitis is Expected to Account for the Largest Market Share During the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Mastitis Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Type
- 5.1.1. Clinical Mastitis
- 5.1.2. Sub-clinical Mastitis
- 5.2. Market Analysis, Insights and Forecast - by Product
- 5.2.1. Antibiotics
- 5.2.2. Surgery
- 5.2.3. Vaccines
- 5.2.4. Pain Killers
- 5.2.5. Other Products
- 5.3. Market Analysis, Insights and Forecast - by Route of Administration
- 5.3.1. Intra-mammary
- 5.3.2. Systemic
- 5.4. Market Analysis, Insights and Forecast - by Therapy
- 5.4.1. Lactating Period
- 5.4.2. Dry Period
- 5.5. Market Analysis, Insights and Forecast - by End User
- 5.5.1. Hospitals and Clinics
- 5.5.2. Veterinary Centers
- 5.5.3. Other End Users
- 5.6. Market Analysis, Insights and Forecast - by Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Middle East and Africa
- 5.6.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Type
- 6. North America Mastitis Market Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Type
- 6.1.1. Clinical Mastitis
- 6.1.2. Sub-clinical Mastitis
- 6.2. Market Analysis, Insights and Forecast - by Product
- 6.2.1. Antibiotics
- 6.2.2. Surgery
- 6.2.3. Vaccines
- 6.2.4. Pain Killers
- 6.2.5. Other Products
- 6.3. Market Analysis, Insights and Forecast - by Route of Administration
- 6.3.1. Intra-mammary
- 6.3.2. Systemic
- 6.4. Market Analysis, Insights and Forecast - by Therapy
- 6.4.1. Lactating Period
- 6.4.2. Dry Period
- 6.5. Market Analysis, Insights and Forecast - by End User
- 6.5.1. Hospitals and Clinics
- 6.5.2. Veterinary Centers
- 6.5.3. Other End Users
- 6.1. Market Analysis, Insights and Forecast - by Type
- 7. Europe Mastitis Market Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Type
- 7.1.1. Clinical Mastitis
- 7.1.2. Sub-clinical Mastitis
- 7.2. Market Analysis, Insights and Forecast - by Product
- 7.2.1. Antibiotics
- 7.2.2. Surgery
- 7.2.3. Vaccines
- 7.2.4. Pain Killers
- 7.2.5. Other Products
- 7.3. Market Analysis, Insights and Forecast - by Route of Administration
- 7.3.1. Intra-mammary
- 7.3.2. Systemic
- 7.4. Market Analysis, Insights and Forecast - by Therapy
- 7.4.1. Lactating Period
- 7.4.2. Dry Period
- 7.5. Market Analysis, Insights and Forecast - by End User
- 7.5.1. Hospitals and Clinics
- 7.5.2. Veterinary Centers
- 7.5.3. Other End Users
- 7.1. Market Analysis, Insights and Forecast - by Type
- 8. Asia Pacific Mastitis Market Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Type
- 8.1.1. Clinical Mastitis
- 8.1.2. Sub-clinical Mastitis
- 8.2. Market Analysis, Insights and Forecast - by Product
- 8.2.1. Antibiotics
- 8.2.2. Surgery
- 8.2.3. Vaccines
- 8.2.4. Pain Killers
- 8.2.5. Other Products
- 8.3. Market Analysis, Insights and Forecast - by Route of Administration
- 8.3.1. Intra-mammary
- 8.3.2. Systemic
- 8.4. Market Analysis, Insights and Forecast - by Therapy
- 8.4.1. Lactating Period
- 8.4.2. Dry Period
- 8.5. Market Analysis, Insights and Forecast - by End User
- 8.5.1. Hospitals and Clinics
- 8.5.2. Veterinary Centers
- 8.5.3. Other End Users
- 8.1. Market Analysis, Insights and Forecast - by Type
- 9. Middle East and Africa Mastitis Market Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Type
- 9.1.1. Clinical Mastitis
- 9.1.2. Sub-clinical Mastitis
- 9.2. Market Analysis, Insights and Forecast - by Product
- 9.2.1. Antibiotics
- 9.2.2. Surgery
- 9.2.3. Vaccines
- 9.2.4. Pain Killers
- 9.2.5. Other Products
- 9.3. Market Analysis, Insights and Forecast - by Route of Administration
- 9.3.1. Intra-mammary
- 9.3.2. Systemic
- 9.4. Market Analysis, Insights and Forecast - by Therapy
- 9.4.1. Lactating Period
- 9.4.2. Dry Period
- 9.5. Market Analysis, Insights and Forecast - by End User
- 9.5.1. Hospitals and Clinics
- 9.5.2. Veterinary Centers
- 9.5.3. Other End Users
- 9.1. Market Analysis, Insights and Forecast - by Type
- 10. South America Mastitis Market Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Type
- 10.1.1. Clinical Mastitis
- 10.1.2. Sub-clinical Mastitis
- 10.2. Market Analysis, Insights and Forecast - by Product
- 10.2.1. Antibiotics
- 10.2.2. Surgery
- 10.2.3. Vaccines
- 10.2.4. Pain Killers
- 10.2.5. Other Products
- 10.3. Market Analysis, Insights and Forecast - by Route of Administration
- 10.3.1. Intra-mammary
- 10.3.2. Systemic
- 10.4. Market Analysis, Insights and Forecast - by Therapy
- 10.4.1. Lactating Period
- 10.4.2. Dry Period
- 10.5. Market Analysis, Insights and Forecast - by End User
- 10.5.1. Hospitals and Clinics
- 10.5.2. Veterinary Centers
- 10.5.3. Other End Users
- 10.1. Market Analysis, Insights and Forecast - by Type
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 Elanco (Bayer AG)
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Boehringer Ingelheim International GmbH
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Advanced Animal Diagnostics
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Merck & Co Inc
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Ceva
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Nimrod Veterinary Products Ltd
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 ImmuCell Corporation
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 West Way Health
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Norbrook
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 DeLaval
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Zoetis Inc
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.1 Elanco (Bayer AG)
List of Figures
- Figure 1: Global Mastitis Market Revenue Breakdown (billion, %) by Region 2025 & 2033
- Figure 2: North America Mastitis Market Revenue (billion), by Type 2025 & 2033
- Figure 3: North America Mastitis Market Revenue Share (%), by Type 2025 & 2033
- Figure 4: North America Mastitis Market Revenue (billion), by Product 2025 & 2033
- Figure 5: North America Mastitis Market Revenue Share (%), by Product 2025 & 2033
- Figure 6: North America Mastitis Market Revenue (billion), by Route of Administration 2025 & 2033
- Figure 7: North America Mastitis Market Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 8: North America Mastitis Market Revenue (billion), by Therapy 2025 & 2033
- Figure 9: North America Mastitis Market Revenue Share (%), by Therapy 2025 & 2033
- Figure 10: North America Mastitis Market Revenue (billion), by End User 2025 & 2033
- Figure 11: North America Mastitis Market Revenue Share (%), by End User 2025 & 2033
- Figure 12: North America Mastitis Market Revenue (billion), by Country 2025 & 2033
- Figure 13: North America Mastitis Market Revenue Share (%), by Country 2025 & 2033
- Figure 14: Europe Mastitis Market Revenue (billion), by Type 2025 & 2033
- Figure 15: Europe Mastitis Market Revenue Share (%), by Type 2025 & 2033
- Figure 16: Europe Mastitis Market Revenue (billion), by Product 2025 & 2033
- Figure 17: Europe Mastitis Market Revenue Share (%), by Product 2025 & 2033
- Figure 18: Europe Mastitis Market Revenue (billion), by Route of Administration 2025 & 2033
- Figure 19: Europe Mastitis Market Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 20: Europe Mastitis Market Revenue (billion), by Therapy 2025 & 2033
- Figure 21: Europe Mastitis Market Revenue Share (%), by Therapy 2025 & 2033
- Figure 22: Europe Mastitis Market Revenue (billion), by End User 2025 & 2033
- Figure 23: Europe Mastitis Market Revenue Share (%), by End User 2025 & 2033
- Figure 24: Europe Mastitis Market Revenue (billion), by Country 2025 & 2033
- Figure 25: Europe Mastitis Market Revenue Share (%), by Country 2025 & 2033
- Figure 26: Asia Pacific Mastitis Market Revenue (billion), by Type 2025 & 2033
- Figure 27: Asia Pacific Mastitis Market Revenue Share (%), by Type 2025 & 2033
- Figure 28: Asia Pacific Mastitis Market Revenue (billion), by Product 2025 & 2033
- Figure 29: Asia Pacific Mastitis Market Revenue Share (%), by Product 2025 & 2033
- Figure 30: Asia Pacific Mastitis Market Revenue (billion), by Route of Administration 2025 & 2033
- Figure 31: Asia Pacific Mastitis Market Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 32: Asia Pacific Mastitis Market Revenue (billion), by Therapy 2025 & 2033
- Figure 33: Asia Pacific Mastitis Market Revenue Share (%), by Therapy 2025 & 2033
- Figure 34: Asia Pacific Mastitis Market Revenue (billion), by End User 2025 & 2033
- Figure 35: Asia Pacific Mastitis Market Revenue Share (%), by End User 2025 & 2033
- Figure 36: Asia Pacific Mastitis Market Revenue (billion), by Country 2025 & 2033
- Figure 37: Asia Pacific Mastitis Market Revenue Share (%), by Country 2025 & 2033
- Figure 38: Middle East and Africa Mastitis Market Revenue (billion), by Type 2025 & 2033
- Figure 39: Middle East and Africa Mastitis Market Revenue Share (%), by Type 2025 & 2033
- Figure 40: Middle East and Africa Mastitis Market Revenue (billion), by Product 2025 & 2033
- Figure 41: Middle East and Africa Mastitis Market Revenue Share (%), by Product 2025 & 2033
- Figure 42: Middle East and Africa Mastitis Market Revenue (billion), by Route of Administration 2025 & 2033
- Figure 43: Middle East and Africa Mastitis Market Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 44: Middle East and Africa Mastitis Market Revenue (billion), by Therapy 2025 & 2033
- Figure 45: Middle East and Africa Mastitis Market Revenue Share (%), by Therapy 2025 & 2033
- Figure 46: Middle East and Africa Mastitis Market Revenue (billion), by End User 2025 & 2033
- Figure 47: Middle East and Africa Mastitis Market Revenue Share (%), by End User 2025 & 2033
- Figure 48: Middle East and Africa Mastitis Market Revenue (billion), by Country 2025 & 2033
- Figure 49: Middle East and Africa Mastitis Market Revenue Share (%), by Country 2025 & 2033
- Figure 50: South America Mastitis Market Revenue (billion), by Type 2025 & 2033
- Figure 51: South America Mastitis Market Revenue Share (%), by Type 2025 & 2033
- Figure 52: South America Mastitis Market Revenue (billion), by Product 2025 & 2033
- Figure 53: South America Mastitis Market Revenue Share (%), by Product 2025 & 2033
- Figure 54: South America Mastitis Market Revenue (billion), by Route of Administration 2025 & 2033
- Figure 55: South America Mastitis Market Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 56: South America Mastitis Market Revenue (billion), by Therapy 2025 & 2033
- Figure 57: South America Mastitis Market Revenue Share (%), by Therapy 2025 & 2033
- Figure 58: South America Mastitis Market Revenue (billion), by End User 2025 & 2033
- Figure 59: South America Mastitis Market Revenue Share (%), by End User 2025 & 2033
- Figure 60: South America Mastitis Market Revenue (billion), by Country 2025 & 2033
- Figure 61: South America Mastitis Market Revenue Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global Mastitis Market Revenue billion Forecast, by Type 2020 & 2033
- Table 2: Global Mastitis Market Revenue billion Forecast, by Product 2020 & 2033
- Table 3: Global Mastitis Market Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 4: Global Mastitis Market Revenue billion Forecast, by Therapy 2020 & 2033
- Table 5: Global Mastitis Market Revenue billion Forecast, by End User 2020 & 2033
- Table 6: Global Mastitis Market Revenue billion Forecast, by Region 2020 & 2033
- Table 7: Global Mastitis Market Revenue billion Forecast, by Type 2020 & 2033
- Table 8: Global Mastitis Market Revenue billion Forecast, by Product 2020 & 2033
- Table 9: Global Mastitis Market Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 10: Global Mastitis Market Revenue billion Forecast, by Therapy 2020 & 2033
- Table 11: Global Mastitis Market Revenue billion Forecast, by End User 2020 & 2033
- Table 12: Global Mastitis Market Revenue billion Forecast, by Country 2020 & 2033
- Table 13: United States Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 14: Canada Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 15: Mexico Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 16: Global Mastitis Market Revenue billion Forecast, by Type 2020 & 2033
- Table 17: Global Mastitis Market Revenue billion Forecast, by Product 2020 & 2033
- Table 18: Global Mastitis Market Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 19: Global Mastitis Market Revenue billion Forecast, by Therapy 2020 & 2033
- Table 20: Global Mastitis Market Revenue billion Forecast, by End User 2020 & 2033
- Table 21: Global Mastitis Market Revenue billion Forecast, by Country 2020 & 2033
- Table 22: Germany Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 23: United Kingdom Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 24: France Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 25: Italy Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 26: Spain Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 27: Rest of Europe Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 28: Global Mastitis Market Revenue billion Forecast, by Type 2020 & 2033
- Table 29: Global Mastitis Market Revenue billion Forecast, by Product 2020 & 2033
- Table 30: Global Mastitis Market Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 31: Global Mastitis Market Revenue billion Forecast, by Therapy 2020 & 2033
- Table 32: Global Mastitis Market Revenue billion Forecast, by End User 2020 & 2033
- Table 33: Global Mastitis Market Revenue billion Forecast, by Country 2020 & 2033
- Table 34: China Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 35: Japan Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 36: India Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 37: Australia Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 38: South Korea Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 39: Rest of Asia Pacific Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 40: Global Mastitis Market Revenue billion Forecast, by Type 2020 & 2033
- Table 41: Global Mastitis Market Revenue billion Forecast, by Product 2020 & 2033
- Table 42: Global Mastitis Market Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 43: Global Mastitis Market Revenue billion Forecast, by Therapy 2020 & 2033
- Table 44: Global Mastitis Market Revenue billion Forecast, by End User 2020 & 2033
- Table 45: Global Mastitis Market Revenue billion Forecast, by Country 2020 & 2033
- Table 46: GCC Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 47: South Africa Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 48: Rest of Middle East and Africa Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 49: Global Mastitis Market Revenue billion Forecast, by Type 2020 & 2033
- Table 50: Global Mastitis Market Revenue billion Forecast, by Product 2020 & 2033
- Table 51: Global Mastitis Market Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 52: Global Mastitis Market Revenue billion Forecast, by Therapy 2020 & 2033
- Table 53: Global Mastitis Market Revenue billion Forecast, by End User 2020 & 2033
- Table 54: Global Mastitis Market Revenue billion Forecast, by Country 2020 & 2033
- Table 55: Brazil Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 56: Argentina Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 57: Rest of South America Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Mastitis Market?
The projected CAGR is approximately 7.2%.
2. Which companies are prominent players in the Mastitis Market?
Key companies in the market include Elanco (Bayer AG), Boehringer Ingelheim International GmbH, Advanced Animal Diagnostics, Merck & Co Inc, Ceva, Nimrod Veterinary Products Ltd, ImmuCell Corporation, West Way Health, Norbrook, DeLaval, Zoetis Inc.
3. What are the main segments of the Mastitis Market?
The market segments include Type, Product, Route of Administration, Therapy, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD 1.3 billion as of 2022.
5. What are some drivers contributing to market growth?
Rising Incidence of the Disease; Increasing Product Launches for Animal Healthcare; Technological Advancements in the Field of Drug Discovery and Development.
6. What are the notable trends driving market growth?
Clinical Mastitis is Expected to Account for the Largest Market Share During the Forecast Period.
7. Are there any restraints impacting market growth?
Rising Threat of Antibiotic Resistance; Lack of Awareness About the Disease.
8. Can you provide examples of recent developments in the market?
In October 2022, NovaQuest Capital Management invested over USD 20 million in Mileutis Ltd, an Israeli biopharmaceuticals company, to help mitigate the use of antibiotics in animals. Mileutics is in the advanced stages of developing a product that treats and prevents bovine mastitis.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Mastitis Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Mastitis Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Mastitis Market?
To stay informed about further developments, trends, and reports in the Mastitis Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence